ACE Inhibitor Selection and Management in Nephrotic Syndrome

Guideline-Based Approach to ACE Inhibitor Selection

The KDIGO 2021 guidelines recommend ACE inhibitors or ARBs as first-line therapy for hypertension and proteinuria in nephrotic syndrome, without specifying superiority of any individual agent within the ACE inhibitor class 1, 2
The guidelines treat all ACE inhibitors as therapeutically equivalent for managing glomerular disease, focusing on the class effect rather than individual drug selection 1, 3

Start with either ramipril or perindopril based on local formulary availability and cost, and titrate to maximally tolerated dose to achieve blood pressure <120/80 mmHg and/or reduce proteinuria to <1 g/day or by at least 50% 1, 2, 3
Do not stop ACEi if serum creatinine increases up to 30% from baseline—this is expected and acceptable 3

Check labs (creatinine, potassium) frequently after initiation and dose adjustments, and counsel patients to hold ACEi during sick days (vomiting, diarrhea, volume depletion) to prevent acute kidney injury 1, 2, 4, 5
Monitor for hyperkalemia and use potassium-wasting diuretics or potassium binders if needed to continue ACEi therapy 1, 2

Do not start ACEi in patients with abrupt-onset nephrotic syndrome (especially minimal change disease) as these drugs can cause acute kidney injury in this setting 3
Delay ACEi initiation in podocytopathies (MCD, steroid-sensitive nephrotic syndrome, FSGS) expected to respond rapidly to immunosuppression, particularly in adults 1, 2
Do not combine ACEi with ARB—this combination increases adverse events without additional benefit in most patients 3
Avoid dihydropyridine calcium channel blockers (amlodipine, nifedipine) as they exacerbate edema and may increase proteinuria 4, 5

Restrict dietary sodium to <2.0 g/day to enhance ACEi effectiveness 1, 2, 3
Consider adding mineralocorticoid receptor antagonists (spironolactone) in refractory cases with persistent proteinuria despite maximal ACEi therapy 1, 2
Use loop diuretics for edema management, but counsel patients to hold both diuretics and ACEi during volume depletion 1, 2, 4